Knockout Ccrk in mouse hepatoma significantly enhances the efficacy of immune checkpoint inhibitor by disrupting immunosuppression and unleashing anti-tumor immune response [135,136]. This evidence concerns the gene CDK20 and hepatocellular carcinoma.